[Nintedanib in the treatment of interstitial lung disease associated with systemic sclerosis: A justified hope?]

[Nintedanib in the treatment of interstitial lung disease associated with systemic sclerosis: A justified hope?] Rev Med Interne. 2019 Aug 30;: Authors: Hachulla E PMID: 31477468 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31477468?dopt=Abstract

Source: Revue de Medecine Interne - September 6, 2019 Category: Internal Medicine Tags: Rev Med Interne Source Type: research

More News: Internal Medicine | Interstitial Lung Disease | Scleroderma